Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 27, 2016
Total Value: $160M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXGN | AXOGEN INC | 2,120,000 | $11.36M | 7.1% | $3.33 | +52.6% | COM | 05463X106 |
| — | ARIAD PHARMACEUTICALS INC | 1,250,000 | $7.988M | 5.0% | $6983.72 | — | COM | 04033A100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 110,000 | $6.964M | 4.3% | $45.89 | +42.6% | COM | 90400D108 |
| — | FIBROGEN INC | 325,000 | $6.919M | 4.3% | $25.76 | — | COM | 31572Q808 |
| — | PROTALIX BIOTHERAPEUTICS INC | 8,200,000 | $6.892M | 4.3% | $1.32 | — | COM | 74365AAB7 |
| — | MEDGENICS INC | 1,557,700 | $6.854M | 4.3% | $5.33 | — | COM NEW | 58436Q203 |
| — | ADAMAS PHARMACEUTICALS INC | 320,000 | $6.064M | 3.8% | $18.87 | — | COM | 00548A106 |
| — | CARA THERAPEUTICS INC | 855,000 | $5.318M | 3.3% | $8.65 | — | COM | 140755109 |
| — | SAGE THERAPEUTICS INC | 165,000 | $5.29M | 3.3% | $46.02 | — | COM | 78667J108 |
| — | AMAG PHARMACEUTICALS INC | 220,000 | $5.148M | 3.2% | $44.20 | — | COM | 00163U106 |
| — | IMPRIMIS PHARMACEUTICALS INC | 1,250,000 | $4.963M | 3.1% | $2987.51 | — | COM NEW | 45323A201 |
| — | INOTEK PHARMACEUTICALS CORP | 645,000 | $4.773M | 3.0% | $5.17 | — | COM | 45780VAA0 |
| — | DEPOMED INC | 325,000 | $4.527M | 2.8% | $17.81 | — | COM | 249908104 |
| AGIO | AGIOS PHARMACEUTICALS INC | 105,000 | $4.263M | 2.7% | $42.75 | 0.0% | COM | 00847X104 |
| — | CYTRX CORP | 1,440,000 | $4.118M | 2.6% | $2.37 | — | COM PAR $.001 | 838828509 |
| — | BLUEPRINT MEDICINES CORP | 220,000 | $3.971M | 2.5% | $23.98 | — | COM | 09627Y109 |
| GERN | GERON CORP | 1,325,000 | $3.869M | 2.4% | $2.63 | +13.8% | COM | 374163103 |
| — | FOAMIX PHARMACEUTICALS LTD | 590,000 | $3.847M | 2.4% | $7.91 | — | SHS | M46135105 |
| CDXS | CODEXIS INC | 1,178,500 | $3.665M | 2.3% | $1.98 | +94.5% | COM | 192005106 |
| TGTX | TG THERAPEUTICS INC | 415,000 | $3.536M | 2.2% | $12.98 | -32.6% | COM | 88322Q108 |
| — | CHIMERIX INC | 675,000 | $3.449M | 2.2% | $5.11 | — | COM | 16934W106 |
| — | OPHTHOTECH CORP | 80,000 | $3.382M | 2.1% | $13006.66 | — | COM | 683745103 |
| — | IMMUNOMEDICS INC | 1,325,000 | $3.313M | 2.1% | $2.62 | — | COM | 452907108 |
| XENE | XENON PHARMACEUTICALS INC | 400,000 | $2.796M | 1.7% | $8.74 | -17.8% | COM | 98420N105 |
| — | AMARIN CORP PLC | 1,760,000 | $2.693M | 1.7% | $2.34 | — | COM | 023111206 |
| — | INTEC PHARMA LTD JERUSALEM | 638,000 | $2.629M | 1.6% | $5.58 | — | SHS | M53644106 |
| — | NABRIVA THERAPEUTICS AG | 273,800 | $2.453M | 1.5% | $9.49 | — | SPONSORED ADR | 62957M104 |
| EGRX | EAGLE PHARMACEUTICALS INC | 60,000 | $2.43M | 1.5% | $71.99 | -11.9% | COM | 269796108 |
| — | AFFIMED N V | 610,000 | $2.281M | 1.4% | $13.23 | — | COM | N01045108 |
| — | ZOGENIX INC | 240,000 | $2.218M | 1.4% | $9.24 | — | COM NEW | 98978L204 |
| — | RETROPHIN INC | 150,000 | $2.049M | 1.3% | $20.71 | — | COM | 761299106 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 125,000 | $1.906M | 1.2% | $8.76 | +48.9% | COM | 868459108 |
| — | TRILLIUM THERAPEUTICS INC | 195,000 | $1.804M | 1.1% | $9.00 | — | COM NEW | 89620X506 |
| — | EDGE THERAPEUTICS INC | 185,000 | $1.693M | 1.1% | $9.15 | — | COM | 279870109 |
| — | CYNAPSUS THERAPEUTICS INC | 121,000 | $1.44M | 0.9% | $15.19 | — | COM PAR NO PAR | 23257Y859 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 175,300 | $1.425M | 0.9% | $8.13 | — | SPONDS ADR | 00653A107 |
| — | CORIUM INTL INC | 360,000 | $1.39M | 0.9% | $8.06 | — | COM | 21887L107 |
| — | AURIS MED HLDG AG | 340,000 | $1.238M | 0.8% | $4.86 | — | COM | H03579101 |
| — | OHR PHARMACEUTICAL INC | 366,000 | $1.175M | 0.7% | $3.21 | — | COM NEW | 67778H200 |
| — | PROTEON THERAPEUTICS INC | 150,000 | $1.161M | 0.7% | $7.74 | — | COM | 7437IL109 |
| — | XOMA CORP DEL | 1,350,000 | $1.044M | 0.7% | $1.44 | — | COM | 98419J107 |
| — | TENAX THERAPEUTICS INC | 499,600 | $1.024M | 0.6% | $3.68 | — | COM | 88032L100 |
| — | ACHAOGEN INC | 255,000 | $704K | 0.4% | $2.76 | — | COM | 004449104 |
| — | NEKTAR THERAPEUTICS | 50,000 | $688K | 0.4% | $13.76 | — | COM | 640268108 |
| — | MEDIVATION INC | 14,500 | $667K | 0.4% | $46.00 | — | COM | 58501N101 |
| — | EVOKE PHARMA | 130,000 | $662K | 0.4% | $474.90 | — | COM | 30049G104 |
| PRTA | PROTHENA CORP PLC | 14,000 | $576K | 0.4% | $39.14 | 0.0% | SHS | G72800108 |
| — | NEURODERM LTD | 38,500 | $544K | 0.3% | $14.13 | — | ORD SHS | M74231107 |
| — | NIVALIS THERAPEUTICS INC | 100,000 | $417K | 0.3% | $4.17 | — | COM | 65481J109 |
| ACRS | ACLARIS THERAPEUTICS INC | 18,000 | $341K | 0.2% | $19.11 | 0.0% | COM | 00461U105 |
| — | BIOLINERX LTD | 250,000 | $255K | 0.2% | $1426.15 | — | SPONSORED ADR | 09071M106 |
| — | CHIASMA INC | 20,000 | $183K | 0.1% | $9.15 | — | COM | 16706W102 |